Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Feb;62(2):259-264.
doi: 10.1038/jhg.2016.120. Epub 2016 Oct 13.

A novel founder MYO15A frameshift duplication is the major cause of genetic hearing loss in Oman

Affiliations

A novel founder MYO15A frameshift duplication is the major cause of genetic hearing loss in Oman

Flavia Palombo et al. J Hum Genet. 2017 Feb.

Abstract

The increased risk for autosomal recessive disorders is one of the most well-known medical implications of consanguinity. In the Sultanate of Oman, a country characterized by one of the highest rates of consanguineous marriages worldwide, prevalence of genetic hearing loss (GHL) is estimated to be 6/10 000. Families of GHL patients have higher consanguinity rates than the general Omani population, indicating a major role for recessive forms. Mutations in GJB2, the most commonly mutated GHL gene, have been sporadically described. We collected 97 DNA samples of GHL probands, affected/unaffected siblings and parents from 26 Omani consanguineous families. Analyzing a first family by whole-exome sequencing, we identified a novel homozygous frameshift duplication (c.1171_1177dupGCCATCT) in MYO15A, the gene linked to the deafness locus DFNB3. This duplication was then found in a total of 8/26 (28%) families, within a 849 kb founder haplotype. Reconstruction of haplotype structure at MYO15A surrounding genomic regions indicated that the founder haplotype branched out in the past two to three centuries from a haplotype present worldwide. The MYO15A duplication emerges as the major cause of GHL in Oman. These findings have major implications for the design of GHL diagnosis and prevention policies in Oman.

PubMed Disclaimer

References

    1. Ann Hum Biol. 2000 May-Jun;27(3):321-6 - PubMed
    1. Hum Mutat. 2007 Oct;28(10):1014-9 - PubMed
    1. F1000Res. 2015 Sep 23;4:891 - PubMed
    1. Am J Hum Genet. 2006 May;78(5):889-96 - PubMed
    1. Hum Mutat. 2016 Oct;37(10):991-1003 - PubMed

LinkOut - more resources